Overview
What is Biotechnology Innovation Organization?
The Biotechnology Innovation Organization (BIO) is a prominent nonprofit association based in Washington, D.C., representing approximately 1,000 member companies, academic institutions, patient groups, and related organizations from across the United States and over 30 countries. Founded on the belief that policy should foster innovation in the life sciences to address challenges in healthcare, agriculture, industry, and the environment, BIO's mission encompasses advocacy and policy efforts, as well as events and member services. With a workforce of 175 individuals, BIO advocates for its members' interests in various sectors, including healthcare, emerging companies, food and agriculture, and industrial and environmental issues. Their advocacy accomplishments include safeguarding intellectual property protections, advancing socially responsible biotechnology use, promoting investments in research, and improving the regulatory climate for biotech products. In the healthcare sector, they have advocated for policies recognizing innovation, safer regulatory environments, and greater patient access to therapies. They also advocate for biosimilars policies that protect patient safety and advance biomedical innovation. BIO's work extends to the international environment, where they have influenced improvements to the regulatory systems for ag-biotech products and supported farmers' rights to plant genetically engineered crops. Additionally, they have advocated for renewable chemicals and sustainably sourced biomass as eligible measures for emissions reduction credit generation.
Official website here: www.bio.org
Is Biotechnology Innovation Organization legitimate?
Biotechnology Innovation Organization is a legitimate nonprofit organization registered as a 501(c)(6) entity. Biotechnology Innovation Organization submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are not tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $7,291,621
Professional Fundraising Fees: $0
Other Salaries and Wages: $20,702,321
For more financial information, click here
Official website here: www.bio.org
What is the mission statement of Biotechnology Innovation Organization?
The Biotechnology Innovation Organization (BIO) is a leading advocacy association with approximately 1,000 member companies and organizations in various sectors, including academia, research institutions, patient groups, and related organizations. Founded on the belief that innovation in the life sciences is essential to address challenges in healthcare, agriculture, industry, and the environment, BIO's mission is to nurture this innovation through policy advocacy and convening events. Their efforts cater to a wide spectrum of biotechnology applications across major sectors, with members representing a diverse range of industries and organizations. BIO's activities are organized into two programs: Advocacy and Services.
Official website here: www.bio.org
Who is the CEO of Biotechnology Innovation Organization?
Rachel King is the Principal Officer of Biotechnology Innovation Organization. The CEO's salary of Biotechnology Innovation Organization is $2,345,095 and their total compensation is $2,643,411.
Official website here: www.bio.org
What is the revenue of Biotechnology Innovation Organization?
Biotechnology Innovation Organization's revenue in 2022 was $103,185,175.
Official website here: www.bio.org
Who are the executives of Biotechnology Innovation Organization and what are their salaries?
The average compensation at Biotechnology Innovation Organization during 2022 was $159,965. There are 175 employees and 102 volunteers at Biotechnology Innovation Organization.
Here are 123 key members and their salaries (Biotechnology Innovation Organization's CEO's salary is $2,345,095 and their total compensation is $2,643,411):
- Michelle Mcmurry-Heath (President And Ceo (Until Nov 2022))
- Richard Masters (Chief Public Affairs & Marketing Officer)
- Nicholas Shipley (Chief Advocacy Officer)
- Elizabeth Esham (Chief Science Officer)
- Stephen Jasko (Chief Financial Officer, Evp Business Development)
- Peter Mchugh (Chief Legal Officer)
- Joseph Damond Thru Jan 2022 (Deputy Chief Policy Officer And Evp In'L Affairs)
- Rachel K King Pres Ceo (Emeritus Board Mem (Since Nov 2022)) [Trustee/Director]
- Julie Louise Gerberding (Assoc Vice Chair/Secy (Until 5/2022)) [Trustee/Director]
- Paul J Hastings (Chair) [Trustee/Director]
- Jeremy M Levin (Immediate Past Chair) [Trustee/Director]
- Elizabeth Lewis (Associate Vice Chair & Secretary) [Trustee/Director]
- Bradford A Zakes (Treasurer) [Trustee/Director]
- John F Crowley (Emerging Companies Section Chair) [Trustee/Director]
- Jennifer Holmgren (Agriculture & Environment Vice Chair) [Trustee/Director]
- Ted W Love (Health Section Vice Chair) [Trustee/Director]
- Erika Smith (Emerging Companies Sect. Vice Chair) [Trustee/Director]
- Sue Washer (Emerging Companies Sect Vc & Secy) [Trustee/Director]
- Sylvia Wulf (Agriculture & Environment Sect Chair) [Trustee/Director]
- Jill Zullo Until Jan 2022 (Agriculture & Environment Co-Chair) [Trustee/Director]
- Angela Carisa Ailloni (Director)
- Steve Albers (Director)
- Bonnie Anderson (Director (Until January 2022))
- Stuart A Arbuckle (Director)
- Martin Babler (Director)
- Doug Berven (Director)
- Sulagna Bhattacharya (Director)
- Jean-Jacques Bienaime (Director)
- Fritz Bittenbender (Director)
- Christopher Boerner (Director)
- Carrie L Bourdow (Director)
- Carine Boustany (Director)
- Stephen Brady (Director)
- Victor Bulto (Director)
- Emmanuel Caeymaex (Director)
- Pablo J Cagnoni (Director)
- Kay Chandler (Director)
- Ivan Cheung (Director)
- Giacomo Chiesi (Director)
- Jeffrey L Cleland (Director)
- Ron Cohen (Director)
- Grace E Colon (Director)
- Bruce C Cozadd (Director)
- Roger Crystal (Director)
- Douglas Doerfler (Director)
- Eric M Dube (Director)
- Marc Dunoyer (Director)
- Mark Enyedy (Director)
- Barry P Flannelly (Director)
- Alexandria Forbes (Director)
- Kaye Foster (Director)
- Cedric Francois (Director)
- John Glasspool (Director)
- Jennifer Good (Director)
- Kevin C Gorman (Director)
- Yvonne Greenstreet (Director)
- Patrick Gruber (Director)
- Chirfi Guindo (Director (Until July 2022))
- Sebastian Guth (Director)
- Steven Harr (Director)
- Rachel Haurwitz (Director)
- Christopher Healey (Director)
- Mike Huckman (Director)
- Elizabeth Jeffords (Director)
- Patrik Jonsson (Director)
- Alex Karnal (Director)
- Daniel Keil (Director (Until February 2022))
- David Kettner (Director)
- Scott Koenig (Director)
- Samarth Kulkarni (Director)
- Joseph J Larosa (Director)
- Chris Leibman (Director)
- John Lepore (Director (Until November 2022))
- Sandy Macrae (Director)
- Gail Maderis (Director)
- Aamir Malik (Director)
- Anthony Mancini (Director)
- John Maraganore (Director)
- Maya Martinez-Davis (Director)
- Sharon Mates (Director)
- Thomas P Mathers (Director)
- John Melo (Director (Until December 2022))
- Sheila Ann Mikhail (Director)
- Bob More (Director (Until June 2022))
- Rocco Morelli (Director)
- Michael M Morrissey (Director)
- Mike Narachi (Director)
- Amir Nashat (Director)
- William J Newell (Director)
- Andrew Obenshain (Director)
- Jannie Oosthuizen (Director)
- Julia Owens (Director)
- John V Oyler (Director)
- Adelene Q Perkins (Director)
- Mark Platt (Director (Until November 2022))
- Richard Pops (Director)
- Mark Pruzanski (Director)
- Sofie Qiao (Director)
- Mike G Raab (Director)
- Anna Rath (Director)
- Elena Rice (Director)
- Howard W Robin (Director (Until December 2022))
- Michael J Ruggiero (Director)
- James Sapirstein (Director)
- Christophe Schilling (Director)
- Christi Shaw (Director)
- Jeffrey Sherman (Director)
- Bill Sibold (Director)
- Nancy Simonian (Director)
- Duane J Simpson (Director)
- Elaine K Sorg (Director)
- Eddie J Sullivan (Director)
- Ian Thompson (Director)
- Linda Trolinder (Director)
- Mark C Trudeau (Director (Until July 2022))
- Oliver Walker (Director (Until March 2022))
- Henrik Wareborn (Director (Until November 2022))
- Neil K Warma (Director)
- Frank Watanabe (Director)
- Scott White (Director)
- Rick E Winningham (Director)
- Roger Wyse (Director)
- John Young (Director (Until January 2022))
Official website here: www.bio.org
Where can I find the form 990 for Biotechnology Innovation Organization?
The Biotechnology Innovation Organization’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.bio.org
Learn more at the official website: www.bio.org
Mission Statement of Biotechnology Innovation Organization
The Biotechnology Innovation Organization (BIO) is a significant advocacy association, representing around 1,000 member companies, academic and research institutions, patient groups, and related organizations from various sectors across the United States and more than 30 countries. Founded on the principle that policy should foster innovation in the life sciences to address challenges in healthcare, agriculture, industry, and the environment, BIO actively engages in advocacy and policy efforts.
BIO's mission revolves around nurturing innovation in the life sciences sector to overcome various hurdles. Its extensive membership base encompasses a diverse range of biotechnology applications, from healthcare to agriculture, industry, and the environment. The organizations and universities that make up BIO play essential roles in shaping the future of the life sciences. BIO's activities are divided into two primary programs: advocacy and services. Through advocacy, the organization lobbies for policies that promote innovation in the life sciences, ensuring a favorable regulatory landscape. The services program offers member benefits such as educational events, networking opportunities, and resources to help its members succeed and contribute to the advancement of the life sciences sector.
Impact
This information is meant to be a general summary of Biotechnology Innovation Organization. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
The Biotechnology Innovation Organization (BIO) has a significant impact on the biotechnology industry through its advocacy efforts and policy initiatives. With approximately 1,000 member companies spanning the United States and over 30 countries, BIO is a powerful force for promoting innovation in the life sciences.
One key area of impact is in advocating for policies that support the development and growth of the biotechnology sector. BIO works to safeguard and advance intellectual property protections, promote investment in research, and foster a regulatory environment that encourages innovation. Additionally, BIO advocates for healthcare policies that recognize the value of innovation and promote patient access to innovative therapies.
BIO's advocacy efforts extend beyond healthcare to areas such as agriculture, industry, and the environment. The organization works with government entities and international organizations to improve the investment and regulatory climate for biotech products, advance the science-based review and approval of biosimilars, and promote the development of new products to combat emerging threats like antimicrobial resistance.
Overall, BIO's impact is seen in its efforts to shape policies that support the growth and success of the biotechnology industry, ultimately benefiting not only its member companies but also patients, consumers, and the broader community.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
CONFERENCE / MEETING REVENUE
Revenue
$37,819,268
MEMBERSHIP DUES
Revenue
$36,288,173
SPECIAL INITIATIVES
Revenue
$2,609,145
CBI LOBBYING FUND
Revenue
$1,059,504
OTHER PROGRAM SERVICES
Revenue
$156,827
Organization Details
Founding Year
1981
Phone
(202) 962-9200
Principal Officer
Rachel King
Main Address
1201 NEW YORK AVE NW NO 1300, WASHINGTON, DC, 20005
Website
www.bio.org
NTEE Category
Code: S40 - Community improvement
If you are a representative of Biotechnology Innovation Organization and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.